Should Publishers Worry About Facebook's New News Feed?
Facebook’s Lindsey Shepard stands by the company’s latest news feed update, despite reports that users are sharing less about themselves on the platform.
“We actually send out thousands of surveys, really every single week, to hear from our community about things that are working for them, things that they love, and also things that honestly, we can be doing better,” the company’s Director of Product Marketing for News Feed, told Cheddar.
“What we’ve heard from people is that when they’re interacting with friends and family, when they’re having those thoughtful discussions and conversations, that feels like time well spent,” Shepard said.
The changes announced last week de-prioritize posts from publishers and brands in an effort to increase user engagement. While Facebook argues only pages with low engagement will be impacted, some outlets fear alienation, with the company even admitting users will spend less time on the platform.
The move may seem ironic given Facebook's recent push to get publishers to invest more heavily on content. But Shepherd isn't worried.
“What’s good for people, and what makes people really enjoy their Facebook experience, is really good for anyone that’s leveraging Facebook for their business."
For full interview [click here](https://cheddar.com/videos/facebooks-lindsey-shepard-talks-the-news-feed-reboot).
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
Dr. Vivek Cherin, Internal Medicine Physician at Amita Health, joined Cheddar's Search for a Cure to break down what we need to know about eligibility and availability of COVID-19 vaccine boosters.
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Carlo and Baker cover Facebook's big rebrand, the latest on Biden's economic agenda and more. Plus, ranking the best Halloween candy and the worst couple's costumes.
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
On this episode of 'Cheddar Innovates': President of iCAD breaks down how its technology is being used as a short-term breast cancer risk estimation for women; A look at Curiosity Stream's 'The Science of Thrills.'
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.